140 related articles for article (PubMed ID: 3293841)
21. Preclinical in vitro evaluation of hematotoxicity of the cisplatin-procaine complex DPR.
Viale M; Minetti S; Ottone M; Lerza R; Parodi B; Pannacciulli I
Anticancer Drugs; 2003 Feb; 14(2):163-6. PubMed ID: 12569303
[TBL] [Abstract][Full Text] [Related]
22. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.
Friedman HS; Krischer JP; Burger P; Oakes WJ; Hockenberger B; Weiner MD; Falletta JM; Norris D; Ragab AH; Mahoney DH
J Clin Oncol; 1992 Feb; 10(2):249-56. PubMed ID: 1732426
[TBL] [Abstract][Full Text] [Related]
23. In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin.
Takahashi H; Sasaki Y; Saijo N; Sakurai M; Nakano H; Nakagawa K; Hoshi A; Jett JR; Hong WS
Cancer Chemother Pharmacol; 1987; 19(3):197-200. PubMed ID: 3034444
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of BCNU-induced cytotoxicity and sister chromatid exchanges by dibromodulcitol in vitro.
Pulst SM; Deen DF
Anticancer Res; 1990; 10(6):1647-50. PubMed ID: 2285238
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of the antitumor activity of newly developed platinum analogs in lung cancer using the colony assay].
Yonei T; Ohnoshi T; Hiraki S; Ueoka H; Yamashita H; Kozuka A; Moritaka T; Uji H; Kiura K; Mima Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):427-30. PubMed ID: 2539056
[No Abstract] [Full Text] [Related]
26. Antitumor activity of a new platinum compound (glycolate-o,o') diammineplatinum (II) (254-S), against non-small cell lung carcinoma grown in a human tumor clonogenic assay system.
Kanzawa F; Matsushima Y; Nakano H; Nakagawa K; Takahashi H; Sasaki Y; Saijo N
Anticancer Res; 1988; 8(3):323-7. PubMed ID: 2839098
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens.
Yonei T; Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Moritaka T; Shibayama T; Tabata M; Segawa Y; Takigawa N
Acta Med Okayama; 1993 Aug; 47(4):233-41. PubMed ID: 8213217
[TBL] [Abstract][Full Text] [Related]
28. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
[TBL] [Abstract][Full Text] [Related]
29. The use of human tumor clonogenic assay in predicting combination effect of cisplatin plus vindesine in carcinoma of the lung.
Kanzawa F; Matsushima Y; Ishihara J; Shimizu E; Sasaki Y; Saijo N; Miyazawa N
J Pharmacobiodyn; 1985 Oct; 8(10):885-8. PubMed ID: 4093843
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
Fukuda M; Ohe Y; Kanzawa F; Oka M; Hara K; Saijo N
Anticancer Res; 1995; 15(2):393-8. PubMed ID: 7763011
[TBL] [Abstract][Full Text] [Related]
31. [The lethal and kinetic effects of carboplatin studied using the human tumor clonogenic assay and flow cytometry].
Fujikane T; Tsuji T; Shimizu T; Onodera S
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1525-37. PubMed ID: 3053943
[No Abstract] [Full Text] [Related]
32. Chromosome number and carmustine sensitivity in human gliomas.
Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
[TBL] [Abstract][Full Text] [Related]
33. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
Sasaki Y; Shinkai T; Eguchi K; Tamura T; Ohe Y; Ohmori T; Saijo N
Cancer Chemother Pharmacol; 1991; 27(4):263-70. PubMed ID: 1847845
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of the chemosensitivity test by subrenal capsule assay].
Terashima M; Ikeda K; Satoh M; Ishida K; Yoshida H; Mori S; Inada K; Yoshida M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):653-8. PubMed ID: 2435246
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacological approach to the platinum compounds].
Sasaki Y
Gan To Kagaku Ryoho; 1992 Apr; 19(4):456-62. PubMed ID: 1313667
[TBL] [Abstract][Full Text] [Related]
36. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
37. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers.
Monk BJ; Alberts DS; Burger RA; Fanta PT; Hallum AV; Hatch KD; Salmon SE
Gynecol Oncol; 1998 Nov; 71(2):308-12. PubMed ID: 9826477
[TBL] [Abstract][Full Text] [Related]
38. Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group study.
Weiss G; Green S; Alberts DS; Thigpen JT; Hines HE; Hanson K; Pierce HI; Baker LH; Goodwin JW
Eur J Cancer; 1991; 27(2):135-8. PubMed ID: 1827275
[TBL] [Abstract][Full Text] [Related]
39. Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery.
Kelland LR; Jones M; Abel G; Valenti M; Gwynne J; Harrap KR
Cancer Chemother Pharmacol; 1992; 30(1):43-50. PubMed ID: 1586979
[TBL] [Abstract][Full Text] [Related]
40. Antitumor effect of two-drug simultaneous or sequential use of cisplatin, vindesine or etoposide on human pulmonary adenocarcinoma cell lines in tumor clonogenic assay.
Lee YC; Saijo N; Sasaki Y; Takahashi H; Sakurai M; Ishihara J; Sano T; Hoshi A; Chen KM; Hamburger AW
Jpn J Cancer Res; 1986 Mar; 77(3):312-8. PubMed ID: 3084421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
